Altimmune Inc (NASDAQ: ALT) kicked off on Friday, up 1.33% from the previous trading day, before settling in for the closing price of $6.79. Over the past 52 weeks, ALT has traded in a range of $2.09-$14.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 115.21% over the last five years. While this was happening, its average annual earnings per share was recorded 16.61%. With a float of $70.48 million, this company’s outstanding shares have now reached $70.68 million.
The firm has a total of 59 workers. Let’s measure their productivity. In terms of profitability, gross margin is -4899.02%, operating margin of -23785.57%, and the pretax margin is -24778.97%.
Altimmune Inc (ALT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Altimmune Inc is 0.83%, while institutional ownership is 59.49%. The most recent insider transaction that took place on Aug 19 ’24, was worth 110,547. In this transaction Director of this company sold 16,011 shares at a rate of $6.90, taking the stock ownership to the 41,958 shares.
Altimmune Inc (ALT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.39 earnings per share (EPS), higher than consensus estimate (set at -0.42) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.61% per share during the next fiscal year.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Take a look at Altimmune Inc’s (ALT) current performance indicators. Last quarter, stock had a quick ratio of 11.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1192.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Analysing the last 5-days average volume posted by the [Altimmune Inc, ALT], we can find that recorded value of 1.85 million was lower than the volume posted last year of 3.89 million. As of the previous 9 days, the stock’s Stochastic %D was 69.95%. Additionally, its Average True Range was 0.43.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 49.92%, which indicates a significant decrease from 73.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.99% in the past 14 days, which was lower than the 78.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.71, while its 200-day Moving Average is $7.94. Now, the first resistance to watch is $7.11. This is followed by the second major resistance level at $7.33. The third major resistance level sits at $7.56. If the price goes on to break the first support level at $6.66, it is likely to go to the next support level at $6.43. Now, if the price goes above the second support level, the third support stands at $6.21.
Altimmune Inc (NASDAQ: ALT) Key Stats
The company with the Market Capitalisation of 488.96 million has total of 70,902K Shares Outstanding. Its annual sales at the moment are 430 K in contrast with the sum of -88,450 K annual income. Company’s last quarter sales were recorded 10 K and last quarter income was -24,640 K.
